Protecting-Group-Free Synthesis of GB1107: An Orally Active Galectin-3 Antagonist

Abstract

Small-molecule galectin inhibitors are useful research tools that could also be used as potential drug candidates. In that context, GB1107, a monosaccharidic galectin inhibitor, was shown to be an orally active galectin-3 antagonist that inhibits lung adenocarcinoma growth. Herein, a protecting-group-free synthesis of GB1107, along with other analogues is described. Starting from inexpensive levoglucosan, a Payne rearrangement/azidation process was used as key step. Finally, the use of a log P determination method based on ¹⁹F NMR spectroscopy was explored to assess the lipophilicity of galectin inhibitors.

Key words

synthetic inhibitors - galectins - GB1107 - TD139 - lipophilicity

Publication History

Received: 24 March 2021

Accepted after revision: 26 May 2021

Accepted Manuscript online:
26 May 2021

Article published online:
27 July 2021

• References

• 1a Barondes SH, Gastronovo V, Cooper DN. W, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K.-I, Leffler H, Liu F.-T, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirier F, Raz A, Rigby PW. J, Rini JM, Wang JL. Cell 1994; 76: 597
• 1b Barondes SH, Cooper DN. W, Gitt MA, Leffler H. J. Biol. Chem. 1994; 269: 20807
• 2a Rabinovich GA, Toscano M, Jackson DA, Vasta G. Curr. Opin. Struct. Biol. 2007; 17: 513
• 2b Liu F.-T, Rabinovich GA. Nat. Rev. Cancer 2005; 5: 29
• 2c Califice S, Castronovo V, van den Brûle F. Int. J. Oncol. 2004; 25: 983
• 2d Rabinovich GA, Toscano M. Nat. Rev. Immunol. 2009; 9: 338
• 2e Di Lella S, Sundblad V, Cerliani JP, Guardia CM, Estrin DA, Vasta GR, Rabinovich GA. Biochemistry 2011; 50: 7842
• 2f Rabinovich GA, Toscano MA, Ilarregui JM, Rubinstein N. Glycoconj. J. 2004; 19: 565
• 3a Bertuzzi S, Quintana JI, Arda A, Gimeno A, Jimenez-Barbero J. Front. Chem. 2020; 8: 593
• 3b Damalanka VC, Maddirala AR, Janetka JW. Expert Opin. Drug Discov. 2021; 16: 513
• 4a Pieters RJ. ChemBioChem 2006; 7: 721
• 4b Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R. Curr. Med. Chem. 2006; 13: 3513
• 4c Öberg CT, Leffler H, Nilsson UJ. Chimia 2011; 65: 18
• 4d Leffler H., Nilsson U. J.; Low-Molecular Weight Inhibitors of Galectins, In Galectins and Disease Implications for Targeted Therapeutics., ACS Symposium Series Vol. 115; Klyosov A. A., Traber P. G.; 2012, 47–59
• 4e Mayo KH. From Carbohydrate to Peptidomimetic Inhibitors of Galectins. In Galectins and Disease Implications for Targeted Therapeutics, ACS Symposium Series Vol. 115. Klyosov AA, Traber PG. 2012: 61-77
• 4f Denavit V, Lainé D, Temblay T, St-Gelais J, Giguère D. Trends Glycosc. Glycotechnol. 2018; 30: SE21
• 5 Nilsson UJ, Leffler H, Henderson N, Sethi T, Mackinnon A. WO2014067986A1, 2014
• 6 Delaine T, Collins P, MacKinnon A, Sharma G, Stegmayr J, Rajput V, Mandal S, Cumpstey I, Larumbe A, Salameh BA, Kahl-Knutsson B, van Hattum H, van Scherpenzeel M, Pieters RJ, Sethi T, Schambye H, Oredsson S, Leffler H, Blanchard H, Nilsson UJ. ChemBioChem 2016; 17: 1759
• 7a Sörme P, Kahl-Knutsson B, Wellmar U, Nilsson UJ, Leffler H. Methods Enzymol. 2003; 362: 504
• 7b Sörme P, Kahl-Knutsson B, Wellmar U, Magnusson B.-G, Leffler H, Nilsson UJ. Methods Enzymol. 2003; 363: 157
• 7c Sörme P, Kahl-Knutsson B, Huflejt M, Nilsson UJ, Leffler H. Anal. Biochem. 2004; 334: 36
• 8a Zetterberg FR, Peterson K, Johnsson RE, Brimert T, Hakansson M, Logan DT, Leffler H, Nilsson UJ. ChemMedChem 2018; 13: 133
• 8b Brimert T, Johnsson R, Leffler H, Nilsson U, Zetterberg F. WO2016120403, 2016
• 9 Vuong L, Kouverianou E, Rooney CM, McHugh BJ, Howie SE. M, Gregory CD, Forbes SJ, Henderson NC, Zetterberg FR, Nilsson UJ, Leffler H, Ford P, Pedersen A, Gravelle L, Tantawi S, Schambye H, Sethi T, MacKinnon AC. Cancer Res. 2019; 79: 1480
• 10 Lardone RD, Garay YG, Parodi P, de la Fuente S, Angeloni G, Bravo EO, Schmider AK, Irazoqui FJ. J. Biol. Chem. 2021; 296: 100375
• 11 Slack RJ, Mills R, Mackinnon AC. Int. J. Biochem. Cell Biol. 2021; 130: 105881
• 12 Stegmayr J, Zetterberg F, Carlsson MC, Huang X, Sharma G, Kahl-Knutson B, Schambye H, Nilsson UJ, Oredesson S, Leffler H. Sci. Rep. 2019; 9: 2186
• 13 Bratteby K, Torkelsson E, L’Estrade ET, Peterson K, Shalgunov V, Xiong M, Leffler H, Zetterberg FR, Olsson TG, Gillings N, Nilsson UJ, Herth MM, Erlandsson M. J. Med. Chem. 2020; 63: 747
• 14a Lemieux RU, Sweda R, Paszkiewicz-Hnatiw E, Spohr U. Carbohydr. Res. 1990; 205: C12
• 14b Oberg CT, Noresson A.-L, Delaine T, Larumbe A, Tejler J, von Wachenfeldt H, Nilsson UJ. Carbohydr. Res. 2009; 344: 1282
• 14c Peterson K, Wymouth-Wilson A, Nilsson UJ. J. Carbohydr. Chem. 2015; 34: 490
• 15a St-Gelais J, Denavit V, Giguère D. Org. Biomol. Chem. 2020; 18: 3903
• 15b Giguère D, St-Gelais J, Denavit V. WO2020248068, 2020
• 16a Ramesh R, Sonawane S, Reddy DS, Bandichhor R. Protecting-Group-Free Synthesis of Drugs and Pharmaceuticals. In Protecting-Group-Free Organic Synthesis: Improving Economy and Efficiency. Fernandes RA. Wiley; Hoboken: 2018: 155-181
• 16b Young IS, BaranP S. Nat. Chem. 2009; 1: 193
• 16c Trost BM. Science 1991; 254: 1471
• 16d Wender PA, Verma VA, Paxton TJ, Pillow TH. Acc. Chem. Res. 2008; 41: 40
• 17a Cordero-Vargas A, Sartillo-Piscil F. Protecting-Group-Free Synthesis in Carbohydrate Chemistry. In Protecting-Group-Free Organic Synthesis. Fernandes RA. Wiley; Hoboken: 2018: 183-200
• 17b Tanaka T. Protecting-Group-Free synthesis of Glycosyl Derivatives, Glycopolymers, and Glycocojugates. In Protecting-Group-Free Organic Synthesis. Fernandes RA. Wiley; Hoboken: 2018: 201-228
• 18a Vasicek T, Spiwok V, Cerveny J, Petraskova L, Bumba L, Vrbata D, Pelantova H, Kren V, Bojarova P. Chem. Eur. J. 2020; 26: 9620
• 18b Dussouy C, Téletchéa S, Lambert A, Charlier C, Botez I, De Ceuninck F, Grandjean C. J. Org. Chem. 2020; 85: 16099
• 18c Tejler J, Leffler H, Nilsson UJ. Bioorg. Med. Chem. Lett. 2005; 15: 2343
• 18d Bergh A, Leffler H, Sundin A, Nilsson UJ, Kann N. Tetrahedron 2006; 62: 8309
• 19 Jalagam PR, Nair SK, Panda M, Regueiro-Ren A. WO2019075045, 2019
• 20 Grindley BT, Thangarasa R. Carbohydr. Res. 1988; 172: 311
• 21 Cerny M, Buban I, Pacak J. Collect. Czech. Chem. Commun. 1963; 28: 1569
• 22a Payne GB. J. Org. Chem. 1962; 27: 3819
• 22b Behrens CH, Ko SY, Sharpless BK, Walker FJ. J. Org. Chem. 1985; 50: 5687
• 22c Yoshino T, Nagata Y, Itoh E, Hashimoto M, Katoh T, Terashima S. Tetrahedron Lett. 1996; 37: 3475
• 22d Yoshino T, Nagata Y, Itoh E, Hashimoto M, Katoh T, Terashima S. Tetrahedron Lett. 1997; 38: 10239
• 23 Saadi J, Wennemers H. Nat. Chem. 2016; 8: 276
• 24a Lowary TL, Hindsgaul O. Carbohydr. Res. 1994; 251: 33
• 24b Reckendorf WM. Sodium Borohydride Reduction of 3-O-Acetyl-1,2:5,6-di-O-isopropylidene-α-d-erythro-hex-3-enofuranose. In Methods in Carbohydrate Chemistry, Vol. 17. Whistler RL, BeMiller JN. Academic Press; New York: 1972: 129-131
• 24c Stevens JD. From d-Glucose by Oxidation of 1,2:5,6-Di-O-isopropylidene-α-d-glucofuranose and Reduction of 1,2:5,6-Di-O-isopropylidene-α-d-ribo-hexofuranos-3-ulose. In Methods in Carbohydrate Chemistry, Vol. 16. Whistler RL, BeMiller JN. Academic Press; New York: 1972: 123-128
• 25 Niu Y, Wang N, Cao X, Ye X.-S. Synlett 2007; 13: 2116
• 26 Xia C, Zhang W, Zhang Y, Chen W, Nadas J, Severin R, Woodward R, Wang B, Wang X, Kronenberg M, Wang PG. ChemMedChem 2009; 4: 1810
• 27 Xu L, Hartz RA, Beno BR, Ghosh K, Shukla JK, Kumar A, Patel D, Kalidindi N, Lemos N, Gautam SS, Kumar A, Ellsworth BA, Shah D, Sale H, Cheng D, Regeiro-Ren A. J. Med. Chem. 2021; 64: 6634
• 28 Ohlsson J, Magnusson G. Carbohydr. Res. 2000; 329: 49
• 29 Linclau B, Wang Z, Compain G, Paumelle V, Fontenelle CQ, Wells N, Weymouth-Wilson A. Angew. Chem. Int. Ed. 2016; 55: 674
• 30a Denavit V, Lainé D, St-Gelais J, Johnson PA, Giguère D. Nat. Commun. 2018; 9: 4721
• 30b St-Gelais J, Bouchard M, Denavit V, Giguère D. J. Org. Chem. 2019; 84: 8509
• 30c St-Gelais J, Lainé D, Johnson PA, Giguère D. Chem. Eur. J. 2020; 26: 13499
• 30d Lainé D, Lessard O, St-Gelais J, Giguère D. Chem. Eur. J. 2021; 27: 3799